Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ARENA PHARMACEUTICALS, INC
01/17 ARENA PHARMACEUTICALS : Technical Reports on Biotech Stocks -- ContraVir Pharma,..
01/13 ACTIVE BIOTECH STOCK NEWS : Peregrine Pharmaceuticals (PPHM), Arena Pharmaceutic..
01/05 ARENA PHARMACEUTICALS : sells underperforming weight loss drug Belviq to focus o..
01/04 ARENA PHARMACEUTICALS : Belviq story
01/04 ARENA PHARMACEUTICALS : and Eisai Amend Marketing and Supply Agreement for BELVI..
2016 ARENA PHARMACEUTICALS : Will Obesity Drug Stocks Become Mainstream Again?
2016 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Announce Regulatory Appr..
2016 ARENA PHARMACEUTICALS : to Present at the 35th Annual J.P. Morgan Healthcare Con..
2016 ARENA PHARMACEUTICALS : Completes Enrollment in Ralinepag Phase 2 Clinical Trial..
2016 ARENA PHARMACEUTICALS ANNOUNCES FOUR : Crohn's & Colitis Foundation's Clinical a..
2016 ARENA PHARMACEUTICALS : to Present at the 28th Annual Piper Jaffray Healthcare C..
2016 ARENA PHARMACEUTICALS : reports 3Q loss
2016 ARENA PHARMACEUTICALS : Reports Third Quarter 2016 Financial Results and Provide..
2016 INVESTIGATION FOR LONG-TERM INVESTOR : ARNA) Announced
2016 ARENA PHARMACEUTICALS : to Release Third Quarter 2016 Financial Results and Prov..
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
01/17 ARENA PHARMACEUTICALS : Technical Reports on Biotech Stocks -- ContraVir Pharma,..
01/13 ACTIVE BIOTECH STOCK NEWS : Peregrine Pharmaceuticals (PPHM), Arena Pharmaceutic..
01/12 EISAI : Acquires All Global Development And Marketing Rights For Chronic Weight ..
01/12 ARENA PHARMACEUTICALS : and Eisai Amend Marketing and Supply Agreement for BELVI..
01/06 ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regul..
01/05 ARENA PHARMACEUTICALS : sells underperforming weight loss drug Belviq to focus o..
01/04 ARENA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Financia..
01/04 ARENA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement (form 8-K..
01/04 ARENA PHARMACEUTICALS : Belviq story
01/04 ARENA PHARMACEUTICALS : and Eisai Amend Marketing and Supply Agreement for BELVI..
More news
Sector news : Biotechnology & Medical Research - NEC
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
01/06DJSanofi Investors Count Cost of Praluent Ruling -- Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
01/13 Arena Pharmaceuticals (ARNA) Presents At 35th Annual J.P. Morgan Healthcare C..
01/12 Arena Pharmaceuticals (ARNA) Presents at 35th Annual J.P. Morgan Healthcare C..
01/06 SNIPPET ROUNDUP : Johnson & Johnson And Shire Make Some Deals, But Disappointmen..
01/05 Arena Turns Page On Belviq - Restructures Deal With Eisai
01/04 Arena bails on selling Belviq, transfers remaining commercialization rights t..
2016 Healthcare bounces back from Trump tantrum
Latest Tweets
01/17BLOCK TRADE (Microcap): $ARNA 750,000 shares @ $1.40 [11:22:51] #BlockTradeAl.. 
01/13Arena Pharmaceuticals (ARNA) Presents At 35th Annual J.P. Morgan Healthcare C.. 
01/10Arena Pharmaceuticals downgraded by Zacks Investment Research to hold.  
01/07Arena Pharmaceuticals's hold rating reiterated at Needham & Company LLC... 
01/06Snippet Roundup: Johnson & Johnson And Shire Make Some Deals, But Disappo.. 
More tweets
Qtime:58
Advertisement
Financials ($)
Sales 2016 52,7 M
EBIT 2016 -70,3 M
Net income 2016 -77,6 M
Debt 2016 74,0 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 7,73x
EV / Sales 2017 14,6x
Capitalization 333 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 3,75 $
Spread / Average Target 174%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..-3.52%333
INCYTE CORPORATION17.21%22 083
QUINTILES IMS HOLDINGS..0.07%18 734
CELLTRION, INC.--.--%10 483
LONZA GROUP AG4.14%9 679
ALKERMES PLC0.72%8 507
More Results